MONIPOL Biotech (“MPL”) is a Clinical Research Organization (CRO) with German and Polish roots and strong European regional partnerships. We offer conducting phase I-IV clinical trials and medical device investigations in a wide range of therapeutic areas and global locations, with a particular focus on early-phase studies. MPL is committed to tailored solutions for the various needs of biotechnology and small/midsize pharma and medical device companies, to support them in bringing new and innovative therapies to market.
Since August 2024, MONIPOL Biotech is part of the PHARMNET Group (pharmnet-cro.com), a CRO based in the Czech Republic founded in 1994. This strategic expansion benefits clients through providing access to countries with a combined population of 150+ mil (Czechia, Hungary, Slovakia, Poland and Germany), local-language monitoring resources as well as excellent relationship with local authorities and KOLs, and a broader scope of services from the combined MONIPOL / PHARMNET team.
You are facing a challenge in preparation for your clinical trial? We are here to help. Our team is ready to offer tailored guidance. Reach out and let’s get the conversation started. We are committed to finding the right solutions for you.
We are not just another CRO. We aspire to be a next generation CRO: the trusted workbench for innovators in biotech, pharma and medtech. We provide insight-based solutions along the value chain customized to your specific needs.
We are hiring! Up for the challenge? At MONIPOL you have your own projects and responsibilities from day one. We facilitate an environment for professional and personal growth.